Stem cell Follow-Up study tests safety for tough Crohn's cases
NCT ID NCT01233960
Summary
This study tested the safety of giving additional stem cell infusions to people with moderate-to-severe Crohn's disease who had already received an initial round of treatment. The 73 participants received three extra infusions over several months to see if continuing treatment was safe and helped control their disease. Researchers monitored side effects while checking if symptoms improved and quality of life got better.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor University Medical Center
Dallas, Texas, 75246, United States
-
Chevy Chase Clinical Research
Chevy Chase, Maryland, 20815, United States
-
Clinical Research of West Florida
Clearwater, Florida, 33765, United States
-
Cotton-O'Neil Clinical Research Center
Topeka, Kansas, 66606, United States
-
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
-
Gastroenterology Center of the Midsouth, PC
Germantown, Tennessee, 38138, United States
-
McGuire Research Institute
Richmond, Virginia, 23249, United States
-
Mount Sinai School of Medicine
New York, New York, 10029, United States
-
Royal Adelaide Hospital
Adelaide, South Australia, Australia
-
Royal Melbourne Hospital
Melbourne, Victoria, Australia
-
Saint Louis Center for Clinical Research
St Louis, Missouri, 63128, United States
-
Shafran Gastroenterology Center
Winter Park, Florida, 32789, United States
-
St. Louis Center for Clinical Studies
St Louis, Missouri, 63128, United States
-
University of California, San Francisco
San Francisco, California, 94115, United States
-
University of Chicago
Chicago, Illinois, 60611, United States
-
University of Maryland, Baltimore
Baltimore, Maryland, 21201, United States
-
University of Otago
Christchurch, New Zealand
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Waikato Hospital
Hamilton, New Zealand
-
Weill Cornell Medical College
New York, New York, 10028, United States
Conditions
Explore the condition pages connected to this study.